Publication | Closed Access
Applications of Deep Learning and Fuzzy Systems to Detect Cancer Mortality in Next-Generation Genomic Data
43
Citations
41
References
2020
Year
Fuzzy SystemsMachine LearningEngineeringDetect Cancer MortalityPrognosisPathologyFuzzy Risk AnalysisComputational MedicineBiomedical Data ScienceInteraction EffectsBiostatisticsMolecular DiagnosticsRadiation OncologyCancer ResearchFuzzy LogicMedicineFuzzy RulesFuzzy Logic SystemDeep LearningCancer RiskCancer GenomicsOncologyHealth Informatics
In the era of advanced precision medicine, next-generation genomic data are crucial to achieve breakthroughs in cancer medicine. Effective cancer mortality risk estimation for genomic data associated with cancer remains a vital challenge. The combination of machine learning algorithms and conventional survival analysis can advance the detection of high-risk missense mutation variants and candidate genes associated with cancer mortality in next-generation genomic data. In this article, a fuzzy logic system combined with machine learning algorithms and conventional survival analysis named FuzzyDeepCoxPH was proposed to identify high-risk missense mutation variants and candidate genes highly associated with cancer mortality. DL-derived abstracted weights and Cox proportional hazards (CoxPH) ratios were used to develop four model-based risk scores to consider the factor importance associated with risk stratification, time-varying effects, and individual and interaction effects among features. Fuzzy rules based on a fuzzy logic system were designed to integrate these considerations by merging four model-based risk scores to develop advanced risk estimation. The clinical features and next-generation sequencing of deoxyribonucleic acid and ribonucleic acid genomic data were used to evaluate FuzzyDeepCoxPH performance. The results indicated that FuzzyDeepCoxPH can effectively distinguish high-risk variants and candidate genes related to cancer mortality. In FuzzyDeepCoxPH, the fuzzy logic system was applied to combine DL-based and CoxPH-based models to provide a comprehensive cancer mortality risk estimation for cancer medicine.
| Year | Citations | |
|---|---|---|
Page 1
Page 1